Glucagon-Like Peptide-1 Limits Myocardial Stunning following Brief Coronary Occlusion and Reperfusion in Conscious Canines

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year

Klas Malmberg, Lars Rydén, Suad Efendić et al. · Journal of the American College of Cardiology · 1995 · 1.6K citations

Diabetes Management, Cardiovascular Disease, Insulin Management +8

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study

Mette Zander, Sten Madsbad, Jan Lysgaard Madsen et al. · The Lancet · 2002 · 1.3K citations

Metabolic Syndrome, Diabetes Management, Glucagon-like Peptide 1 +9

Effects of Glucagon-Like Peptide-1 in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction After Successful Reperfusion

Lazaros A. Nikolaidis, Sunil Mankad, George Sokos et al. · Circulation · 2004 · 895 citations

Metabolic Modulation of Acute Myocardial Infarction

Ernesto Paolasso, Leopoldo Soares Piegas, Carlos Tajer et al. · Circulation · 1998 · 519 citations

Recombinant Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake and Improves Left Ventricular Performance in Conscious Dogs With Pacing-Induced Dilated Cardiomyopathy

Lazaros A. Nikolaidis, Dariush Elahi, Teresa Hentosz et al. · Circulation · 2004 · 512 citations · Full text